» Articles » PMID: 34349659

The Role of HSP90α in Methamphetamine/Hyperthermia-Induced Necroptosis in Rat Striatal Neurons

Overview
Journal Front Pharmacol
Date 2021 Aug 5
PMID 34349659
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Methamphetamine (METH) is one of the most widely abused synthetic drugs in the world. The users generally present hyperthermia (HT) and psychiatric symptoms. However, the mechanisms involved in METH/HT-induced neurotoxicity remain elusive. Here, we investigated the role of heat shock protein 90 alpha (HSP90α) in METH/HT (39.5°C)-induced necroptosis in rat striatal neurons and an rat model. METH treatment increased core body temperature and up-regulated LDH activity and the molecular expression of canonical necroptotic factors in the striatum of rats. METH and HT can induce necroptosis in primary cultures of striatal neurons. The expression of HSP90α increased following METH/HT injuries. The specific inhibitor of HSP90α, geldanamycin (GA), and shRNA attenuated the METH/HT-induced upregulation of receptor-interacting protein 3 (RIP3), phosphorylated RIP3, mixed lineage kinase domain-like protein (MLKL), and phosphorylated MLKL. The inhibition of HSP90α protected the primary cultures of striatal neurons from METH/HT-induced necroptosis. In conclusion, HSP90α plays an important role in METH/HT-induced neuronal necroptosis and the HSP90α-RIP3 pathway is a promising therapeutic target for METH/HT-induced neurotoxicity in the striatum.

Citing Articles

Cleaving PINK1 or PGAM5? Involvement of PARL in Methamphetamine-Induced Excessive Mitophagy and Neuronal Necroptosis.

An D, Zhang C, Zhou P, Wang Y, Meng S, Chen Y CNS Neurosci Ther. 2025; 31(2):e70293.

PMID: 40013375 PMC: 11865887. DOI: 10.1111/cns.70293.


Microglia contribute to methamphetamine reinforcement and reflect persistent transcriptional and morphological adaptations to the drug.

Vilca S, Margetts A, Hoglund L, Fleites I, Bystrom L, Pollock T Brain Behav Immun. 2024; 120:339-351.

PMID: 38838836 PMC: 11269013. DOI: 10.1016/j.bbi.2024.05.038.


Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.

Ban X, Wan H, Wan X, Tan Y, Hu X, Ban H Curr Med Sci. 2024; 44(1):28-50.

PMID: 38336987 DOI: 10.1007/s11596-024-2832-z.


Active compounds from flowers act via PI3K and ERK signaling pathways to offer neuroprotective effects against Parkinson's disease.

Zhang X, Wang R, Finiuk N, Stoika R, Lin H, Wang X Food Sci Nutr. 2024; 12(1):450-458.

PMID: 38268908 PMC: 10804118. DOI: 10.1002/fsn3.3792.


Microglia contribute to methamphetamine reinforcement and reflect persistent transcriptional and morphological adaptations to the drug.

Vilca S, Margetts A, Fleites I, Wahlestedt C, Tuesta L bioRxiv. 2023; .

PMID: 37961443 PMC: 10634674. DOI: 10.1101/2023.10.19.563168.


References
1.
Chatterjee A, Dimitropoulou C, Drakopanayiotakis F, Antonova G, Snead C, Cannon J . Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis. Am J Respir Crit Care Med. 2007; 176(7):667-75. PMC: 1994236. DOI: 10.1164/rccm.200702-291OC. View

2.
Simon S, Richardson K, Dacey J, Glynn S, Domier C, Rawson R . A comparison of patterns of methamphetamine and cocaine use. J Addict Dis. 2002; 21(1):35-44. DOI: 10.1300/j069v21n01_04. View

3.
Weinlich R, Oberst A, Beere H, Green D . Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol. 2016; 18(2):127-136. DOI: 10.1038/nrm.2016.149. View

4.
Ren W, Tao J, Wei Y, Su H, Zhang J, Xie Y . Time-Dependent Serum Brain-Derived Neurotrophic Factor Decline During Methamphetamine Withdrawal. Medicine (Baltimore). 2016; 95(5):e2604. PMC: 4748886. DOI: 10.1097/MD.0000000000002604. View

5.
Kumar P, Nagarajan A, Uchil P . Analysis of Cell Viability by the Lactate Dehydrogenase Assay. Cold Spring Harb Protoc. 2018; 2018(6). DOI: 10.1101/pdb.prot095497. View